StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) income statement

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3046% above fair value
$633.98−12.89 (-1.99%)

Close on Nov 19, 2026Market cap $17.73BP/E 35.2Yield –

Medpace Holdings, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
21.4%
Net margin
18.2%
Return on equity, FY2025
70.2%

Financial strength

Current ratio
0.83
Debt to equity
–
Debt to assets
–
Cash to current liabilities
47.1%

Valuation

P/E ratio
35.2
Price to sales
6.25
Price to book
30.32
Dividend yield
–

See a number that looks wrong?